Hello, everyone, and how are you today? We are doing just fine, thank you, especially now that the Pharmalot campus has quieted down. Both Mrs. Pharmalot and the shortest person have left for their respective destinations, and the official mascots are snoozing contentedly in their usual spots. This leaves us to forage for interesting items for you. On that note, here are some tidbits. Have a wonderful day and do let us know about juicy developments …
An experimental rheumatoid arthritis drug from Johnson & Johnson was linked to more deaths than a placebo, Food and Drug Administration staff reviewers wrote in an advance of a Wednesday expert panel meeting, Reuters writes. Other possible safety issues were similar to other drugs in the class, but the trend of increased overall mortality “seems unique” for this medicine, they wrote. The most common causes of death were major heart problems, infection, and malignancies.
About the Author Reprints
